RE: Joint Broker Appointed26 Feb 2024 08:35
Does not seem the case. However, it makes me wonder why they have gone through such a big restructuring to then perform significantly worse than the previous management. The previous team had a successful delivery of the vaccine, was bringing in clients and supporting world-class R&D. Now that they are a pure-play CDMO, they only seem to be able to sink the share price.